查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1820175

數位治療市場報告，按應用（糖尿病、肥胖症、心血管疾病、中樞神經系統疾病、呼吸系統疾病、戒菸等）、最終用途（患者、提供者、付款人、雇主等）和地區分類，2025 年至 2033 年

Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球數位治療市場規模達71億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到287億美元，2025-2033年期間的複合年成長率（CAGR）為16.8%。北美是該市場的主導地區，因為該地區擁有完善的醫療基礎設施、強大的技術進步以及對數位醫療的大量投資。此外，由於醫療支出不斷成長、慢性病患病率上升、老年人口不斷成長以及技術進步提供了便捷、經濟高效的個人化醫療服務，該市場也在不斷擴張。

數位治療市場趨勢：

醫療保健技術發展

由於技術的不斷進步，特別是在行動應用程式、人工智慧 (AI) 和機器學習 (ML) 方面的進步，數位治療市場正在快速成長。這些進步促進了先進數位平台的創建，這些平台能夠提供客製化的治療計劃、處理大量健康資料並即時追蹤患者活動。基於人工智慧的演算法正在增強診斷能力，從而能夠早期診斷疾病並進行更有針對性的干涉。此外，穿戴式科技的發展補充了血壓、心率和血糖水平等不同的生理指標，有助於患者和醫護人員積極主動地進行疾病管理。將這些技術整合到醫療保健系統中可以改善患者的治療效果，並消除面對面諮詢的必要性，使治療更加方便和有效。 IMARCIMARC Group預測，到 2033 年，全球醫療保健人工智慧市場規模預計將達到 687 億美元。

慢性病發生率上升

慢性病發生率的上升是市場的主要驅動力之一。糖尿病、肥胖症、心血管疾病和呼吸系統疾病等慢性疾病在全球日益普遍，這主要是由於人口老化、缺乏體能活動和不健康飲食等原因造成的。數位療法透過提供即時監測和客製化干涉措施，為長期病情管理提供了解決方案。例如，糖尿病患者可以使用數位平台監測血糖水平，調整胰島素劑量，並根據即時回饋獲得飲食建議。同樣，心臟病患者可以利用數位療法追蹤生命徵象，接收超出範圍的結果通知，並遵循規定的治療方案。這些技術使患者能夠更好地控制病情，最大限度地減少反覆去醫院的需要，並提高他們的整體生活品質。 2024 年，處方醫療解決方案 Digital Therapeutics(TM) 領域的領導者 Click Therapeutics, Inc. 透露，有意透過收購 Better Therapeutics, Inc. 的資產，加速其在肥胖症和心臟代謝疾病方面的發展力度。收購的資產包括 AspyreRx (BT-001)，這是 FDA 批准的首個用於治療 2 型糖尿病的處方數位干預產品，以及 BT-004，該產品最近獲得 FDA 突破性設備稱號，用於治療代謝功能障礙相關脂肪性肝炎 (MASH)。

個人化醫療需求增加

根據數位治療市場報告，個人化醫療正成為醫學領域的焦點。患者越來越期望獲得根據自身需求量身定做的治療方案，包括考慮基因、生活方式和特定健康狀況等因素。數位治療使臨床醫生能夠利用即時資訊客製化治療方案，從而提供更個人化的治療。這些平台可以利用穿戴式裝置、健康史和患者自我報告的資料，制定高度個人化的治療方案。例如，心理應用程式利用患者情緒、睡眠和行為訊息來調整治療方法，例如認知行為療法 (CBT)。同樣，慢性病數位療法能夠追蹤病情進展，並根據這些資訊調整治療方案。個人化醫療正在徹底改變醫療保健，使患者能夠主動管理自身病情，從而提高治療效果和參與度。隨著個人化治療需求的日益成長，數位治療正成為個人化治療不可或缺的一部分。 2024年，Merz Therapeutics推出iFlexo，這是一款客製化的數位解決方案，旨在改善中風後痙攣患者的康復，體現了其持續致力於幫助中風倖存者的奉獻精神。該應用程式與S3 Connected Health合作開發，提供針對性的運動和復健計劃，旨在增強輕度至中度痙攣患者的活動能力。透過提供結構化的鍛煉，iFlexo致力於幫助中風倖存者恢復獨立生活，並提高他們的整體生活品質。 Merz Therapeutics是唯一一家專注於神經毒素研究並提供自我康復支持平台的製藥公司。

數位治療市場成長動力：

監管支援和醫療報銷

數位治療產業發展的關鍵促進因素之一是這些平台日益成長的監管支持和報銷機制的建立。美國食品藥物管理局 (FDA) 等監管機構正在積極驗證數位治療是否為適當的醫療干預措施。 FDA 制定了新的軟體治療核准指南，簡化了數位治療公司將產品推向市場的流程。這項監管批準確保了數位治療的安全有效，從而獲得了更多醫療服務提供者和患者的認可。此外，報銷政策也在不斷發展以適應數位治療，越來越多的保險公司認知到這些解決方案在改善患者治療效果和降低醫療成本方面的價值。隨著數位治療報銷範圍的擴大，這些解決方案的經濟可近性也在提高，使更多患者能夠從中受益。監管和報銷方面的進展為數位治療在主流醫療保健中的更廣泛應用鋪平了道路。

更加重視心理健康

人們對精神健康障礙的認知日益加深，這推動了市場的成長。焦慮、憂鬱和創傷後壓力症候群 (PTSD) 等精神健康障礙的發生率不斷上升，對有效且價格合理的治療方案的需求也日益成長。數位療法透過提供可擴展、易於實施且可在家中完成的解決方案，為精神健康障礙的治療開闢了新的可能性。行動應用程式、線上治療網站和電腦化認知行為療法 (CBT) 計畫正變得越來越受歡迎，因為它們為患者提供了標準門診治療之外的選擇。這些選擇對於居住在農村或低度開發地區、難以獲得心理健康專業人士幫助的人尤其有用。此外，線上心理健康網站提供了一定程度的匿名性，可以減少尋求幫助的恥辱感。

消費者對便利性和遠距醫療的偏好

對便捷遠距醫療產品和服務的偏好正在推動市場成長。如今，患者越來越希望獲得能夠融入其積極生活方式的醫療保健解決方案，以便他們能夠自行照顧自身健康，而無需反覆前往診所或醫院。數位療法透過提供隨時隨地可用的工具來滿足這項需求，幫助患者以自己的步調掌控健康。例如，慢性病患者可以使用行動應用程式和穿戴式技術來監測自身症狀、生命徵象並獲得治療建議。此外，數位平台也方便與醫療專業人員進行遠距會診，從而減少出行需求並降低醫療費用。

數位治療市場細分：

按應用分類：

  • 糖尿病
  • 肥胖
  • 化學氣相沉積
  • 中樞神經系統疾病
  • 呼吸系統疾病
  • 戒菸
  • 其他

糖尿病佔據了大部分市場佔有率

糖尿病佔據最大的市場佔有率，因為它影響著全球數百萬人。此外，該領域的數位療法利用尖端技術監測血糖水平、管理胰島素劑量並提供個人化的飲食和運動建議。這些工具旨在透過使疾病管理更易於訪問和高效來穩定患者病情並提高生活品質。因此，領先的市場參與者正在推出先進的產品來滿足這些需求。例如，2023 年 10 月 16 日，心臟代謝疾病處方數位療法 (PDT) 領域的傑出領導者 Better Therapeutics, Inc. 宣布商業發布 AspyreRx。這是第一個獲得美國食品藥物管理局 (FDA) 批准作為管理成人 2 型糖尿病 (T2D) 的 II 類設備的認知行為療法 (CBT) 應用程式。它允許醫療保健提供者開立 AspyreRx 處方，該應用程式可從 Apple App Store 和 Google Play Store 下載。

依最終用途分類：

  • 患者
  • 提供者
  • 付款人
  • 雇主
  • 其他

患者佔業界最大佔有率

根據數位治療行業概覽，由於以患者為中心的醫療保健模式日益普及，以及智慧型手機和網際網路服務的廣泛應用，患者成為最大的細分市場，這使得獲取治療應用更加便捷。這些數位解決方案為患者提供各種疾病的客製化治療方案，包括糖尿病、高血壓等慢性疾病以及精神健康障礙。此外，這些應用程式透過個人化護理計劃和即時健康追蹤來管理健康狀況的便利性和有效性，極大地促進了患者對其的採用。醫療保健數位化的不斷發展以及向預防性醫療保健措施的轉變進一步推動了這一趨勢，鞏固了患者在數位治療市場的主導地位。因此，主要參與者正在合作並推出先進的產品。例如，2023年7月5日，瑞思邁宣布收購領先的睡眠和呼吸照護數位診斷軟體供應商Somnoware。此次收購擴展了瑞思邁的睡眠管理軟體功能，透過增強的睡眠實驗室和醫生工具，促進更有效率的患者診斷和長期治療。 Somnoware 平台將補充瑞思邁現有的 AirView 和 Brightree 後偵測解決方案，並將繼續以開放平台的形式運作。這種開放性使睡眠實驗室、肺功能檢測機構和醫生能夠存取各種檢測解決方案的結果，從而加快確診患者獲得所需治療的進程。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據最大的數位治療市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是數位療法最大的區域市場。

北美是該市場的領先地區。該地區數位治療市場的成長因素包括完善的醫療基礎設施、強勁的技術進步以及對數位健康的大量投資。此外，美國數位治療市場的成長主要得益於醫療服務提供者和患者對數位健康技術的廣泛採用。此外，北美主要數位治療公司的存在，加上有利的政府政策和人們對數位治療益處日益成長的認知，進一步推動了市場的成長。例如，2023年11月7日，虛擬心臟代謝護理領域的領導者Vida Health與高級日常穿戴裝置領域的主要參與者Withings Health Solutions合作，為Vida會員提供頂級數位監測設備。此次合作使符合條件的Vida會員可以使用Withings Body Pro蜂窩體重計、BPM Connect Pro蜂窩血壓監測儀或兩者兼有。 Vida的護理團隊獲得了可靠且一致的患者生成的健康資料，從而透過使用這些設備增強了他們的個人化護理策略並改善了健康結果。

（請注意，這只是關鍵參與者的部分名單，完整名單將在報告中提供。）

  • 目前，各公司正在策略性地增強其產品服務，擴大其覆蓋範圍，以促進數位療法市場的成長。此外，他們努力的核心是與成熟的醫療機構和保險公司建立合作夥伴關係，這有助於將數位療法融入主流醫療實踐，並提高患者的可及性。此外，各公司也不斷創新，推動其技術進步，透過更個人化和有效的治療來提高患者的參與度和治療效果。同時，各公司也積極爭取監管部門的批准，以確保合規性並提升市場信譽，這對於數位療法的廣泛應用至關重要。此外，各公司也投資進行教育活動，以提高醫療專業人士和患者對數位療法益處的認知，旨在轉變觀念，建立信任。這些共同努力對於推動數位療法在醫療領域的應用和長期發展至關重要。

本報告回答的關鍵問題

  • 2024 年全球數位治療市場規模是多少
  • 2025-2033年全球數位治療市場的預期成長率是多少
  • 推動全球數位治療市場的關鍵因素有哪些
  • COVID-19 對全球數位治療市場有何影響
  • 根據應用情況，全球數位治療市場如何分類？
  • 根據最終用途，全球數位治療市場如何分類
  • 全球數位治療市場的主要區域有哪些
  • 全球數位治療市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 2024年全球數位治療市場規模？ 2025-2033年全球數位治療市場的預期成長率是多少？
  • 推動全球數位治療市場發展的關鍵因素有哪些？
  • COVID-19 對全球數位治療市場有何影響？
  • 根據應用，全球數位治療市場如何分佈？
  • 根據最終用途，全球數位治療市場如何分類？
  • 全球數位治療市場的主要區域有哪些？
  • 全球數位治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球數位治療市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依應用

  • 糖尿病
  • 肥胖
  • 化學氣相沉積
  • 中樞神經系統疾病
  • 呼吸系統疾病
  • 戒菸
  • 其他

第 7 章：市場區隔：最終用途別

  • 患者
  • 提供者
  • 付款人
  • 雇主
  • 其他

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 2Morrow Inc.
    • Canary Health Inc.
    • Click Therapeutics Inc.
    • Mango Health Inc. (TrialCard Incorporated)
    • Noom Health Inc.
    • Omada Health Inc.
    • Pear Therapeutics, Inc.
    • Propeller Health (ResMed)
    • Teladoc Health Inc.
    • Voluntis Inc.
    • WellDoc Inc.
Product Code: SR112025A3889

The global digital therapeutics market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 28.7 Billion by 2033, exhibiting a growth rate (CAGR) of 16.8% during 2025-2033. North America is the dominant region in the market because it has an established healthcare infrastructure, strong technology advancements, and high investment in digital health in the region. Moreover, the market is expanding due to rising healthcare expenditure, increasing prevalence of chronic diseases, the growing geriatric population, and technological advancements offering easily accessible, cost-effective, personalized medical treatments.

Digital Therapeutics Market Trends:

Technological Developments in Healthcare

The market for digital therapeutics is growing at a rapid pace because of the relentless progress in technology, especially in mobile applications, artificial intelligence (AI), and machine learning (ML). These advancements are facilitating the creation of advanced digital platforms that are capable of providing customized treatment plans, processing large volumes of health data, and tracking patient activity in real-time. Algorithms based on AI are enhancing diagnostic capabilities, enabling early diagnosis of disease and more targeted interventions. Additionally, the development of wearable technology, which complements different physiological measures, such as blood pressure, heart rate, and blood glucose levels, is facilitating patients and healthcare workers to be proactive in disease management. The integration of these technologies into healthcare systems is enhancing patient outcomes and eliminating the necessity for in-person consultations, making treatment more convenient and effective. IMARC Group predicts that the global artificial intelligence in healthcare market is projected to reach USD 68.7 Billion by 2033.

Rising Incidence of Chronic Diseases

The rising occurrence of chronic diseases is one of the primary drivers of market. Chronic diseases like diabetes, obesity, cardiovascular diseases, and respiratory ailments are becoming prevalent globally, largely because of reasons such as aging populations, a lack of physical activity, and unhealthy diets. Digital therapeutics provide a solution for long-term condition management by offering real-time monitoring and tailored interventions. For instance, diabetic patients can use digital platforms to monitor their blood glucose levels, modify their insulin dosage, and get diet suggestions based on real-time feedback. Likewise, heart disease patients can utilize digital therapeutics to track vital signs, get notifications for out-of-range results, and follow prescribed treatment protocols. These technologies allow for patients to better control their conditions, minimizing the need for repeated trips to the hospital and enhancing their overall quality of life. In 2024, Click Therapeutics, Inc., a frontrunner in Digital Therapeutics(TM) as prescription medical solutions, revealed intentions to expedite its development efforts in obesity and cardiometabolic conditions through purchasing the assets of Better Therapeutics, Inc. The acquired assets comprise AspyreRx (BT-001), the inaugural FDA-authorized prescription digital intervention for type 2 diabetes, and BT-004, which recently received FDA Breakthrough Device Designation for addressing metabolic dysfunction-associated steatohepatitis (MASH).

Increased Demand for Personalized Healthcare

As per digital therapeutics market report, personalized healthcare is emerging as the central focus in medicine. Increasingly, patients expect therapies that are customized to their own requirements, including considerations such as genetics, lifestyle, and particular health status. Digital therapeutics allow clinicians to provide more personalized therapies by employing real-time information to customize treatment plans. The platforms can draw on data from wearable devices, health histories, and self-reported information to generate extremely personalized treatment plans. For instance, psychological apps utilize information regarding a patient's mood, sleep, and behavior to modify therapeutic treatments such as cognitive behavioral therapy (CBT). Likewise, chronic condition digital therapeutics are capable of tracking disease advancement and modifying treatments based on the information. Personalized healthcare is revolutionizing healthcare by enabling patients to actively manage their condition, enhancing both treatment efficacy and participation. With the need for personalized therapies increasing, digital therapeutics are becoming integral parts of personalized treatments. In 2024, Merz Therapeutics introduces iFlexo, a tailored digital solution designed to improve rehabilitation for individuals experiencing post-stroke spasticity, reflecting its continuous dedication to assisting stroke survivors. The application, created in partnership with S3 Connected Health, offers specific exercises and rehabilitation plans designed to enhance mobility for individuals experiencing mild to moderate spasticity. Through providing structured exercises, iFlexo seeks to assist stroke survivors in reclaiming their independence and enhancing their overall life quality. Merz Therapeutics is the sole pharmaceutical company specializing in neurotoxins that provides a platform for self-rehabilitation support.

Digital Therapeutics Market Growth Drivers:

Regulatory Support and Healthcare Reimbursement

One of the key drivers behind the digital therapeutics industry is the growing regulatory support and creation of reimbursement mechanisms for these platforms. Regulators such as the U.S. Food and Drug Administration (FDA) are actively engaging in the verification of digital therapeutics as proper medical interventions. The FDA has established new guidelines for the approval of software-based treatments, which is streamlining the process for digital therapeutics companies to take their products to market. This regulatory approval ensures that digital therapeutics are safe and effective, thus gaining more acceptance from healthcare providers and patients. Moreover, reimbursement policies are evolving to accommodate digital therapeutics, with more insurance companies recognizing the value of these solutions in improving patient outcomes and reducing healthcare costs. As reimbursement for digital therapies becomes more widespread, the financial accessibility of these solutions is improving, allowing more patients to benefit from them. This regulatory and reimbursement progress is paving the way for the broader adoption of digital therapeutics in mainstream healthcare.

Greater Emphasis on Mental Health

The increasing recognition of mental health disorders is supporting the market growth. Mental health disorders like anxiety, depression, and post-traumatic stress disorder (PTSD) are rising in frequency, and there is a growing need for effective, affordable treatments. Digital therapeutics are opening up new possibilities for treating mental health disorders by presenting scalable, easy-to-deliver solutions that can be delivered from home. Mobile apps, online therapy websites, and computerized cognitive behavioral therapy (CBT) programs are becoming increasingly popular as they provide patients with an option to standard in-office therapy. These options are especially useful for those who live in rural or underdeveloped areas, where access to mental health professionals is limited. In addition, online mental health websites offer a level of anonymity that can decrease the stigma of seeking help.

Consumer Preference for Convenience and Remote Healthcare

The preferences for convenient, remote healthcare products and services is bolstering the market growth. Today's patients increasingly want healthcare solutions that are integrated into their active lifestyle, so they can take care of themselves without having to pay repeated visits to clinics or hospitals. Digital therapeutics are addressing this need by offering tools that are available whenever and wherever needed, helping patients to control their health at their own pace. For instance, individuals suffering from chronic diseases can monitor their symptoms, monitor their vital signs, and receive treatment advice using mobile applications and wearable technology. Furthermore, digital platforms also facilitate remote consultations with medical professionals, curbing the necessity of travel and lowering healthcare expenses.

Digital Therapeutics Market Segmentation:

Breakup by Application:

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Diabetes accounts for the majority of the market share

Diabetes holds the largest market share as it is a condition that affects millions globally. Additionally, digital therapeutics in this area leverage cutting-edge technology to monitor blood sugar levels, administer insulin doses, and provide personalized dietary and exercise recommendations. These tools aim to stabilize patient conditions and enhance the quality of life by making disease management more accessible and efficient. Hence, leading market players are introducing advanced product variants to meet these needs. For instance, on 16 October 2023, Better Therapeutics, Inc., a prominent leader in prescription digital therapeutics (PDTs) for cardiometabolic conditions, announced the commercial release of AspyreRx. This is the first cognitive behavioral therapy (CBT) app to gain U.S. Food and Drug Administration (FDA) approval as a Class II device for managing type 2 diabetes (T2D) in adults. It allows healthcare providers to prescribe AspyreRx, which is accessible for download from the Apple App Store and Google Play Store.

Breakup by End Use:

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Patients holds the largest share of the industry

According to the digital therapeutics industry overview, patients represent the largest segment due to the increasing patient-centric healthcare approach and the widespread adoption of smartphones and internet services, which facilitate easy access to therapeutic applications. These digital solutions offer patients tailored treatments for a range of conditions, including chronic diseases such as diabetes and hypertension, as well as mental health disorders. Additionally, the convenience and efficacy of these applications in managing health conditions through personalized care plans and real-time health tracking significantly contribute to their adoption among patients. This trend is further supported by growing healthcare digitization and a shift toward preventive healthcare measures, reinforcing the dominant position of patients in the digital therapeutics market. Therefore, major players are collaborating and launching sophisticated product variations. For instance, on 5 July 2023, ResMed announced the acquisition of Somnoware, a leading provider of digital diagnostics software for sleep and respiratory care. This acquisition expanded ResMed's sleep management software capabilities, facilitating more efficient patient diagnosis and long-term treatment through enhanced sleep labs and physician tools. The Somnoware platform will complement ResMed's existing post-testing solutions, AirView and Brightree, and will continue to operate as an open platform. This openness allows sleep labs, pulmonary function testing facilities, and physicians to access results from various testing solutions, accelerating the process of getting diagnosed patients the treatment they need.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest digital therapeutics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for digital therapeutics.

North America represents the leading region in the market. The digital therapeutics market growth factors for the region include the well-established healthcare infrastructure, robust technological advancements, and significant investment in digital health across the region. Moreover, the United States is primarily driven by the widespread adoption rate of digital health technologies among healthcare providers and patients alike. Besides, the presence of major digital therapeutics companies in North America, coupled with favorable government policies and a growing awareness about the benefits of digital therapeutics, further propel the market growth. For instance, on 7 November 2023, Vida Health, a leader in virtual cardiometabolic care, partnered with Withings Health Solutions, a key player in advanced everyday wearables, to provide top-tier digital monitoring devices to Vida members. This partnership offered eligible Vida members access to a Withings Body Pro cellular scale, a BPM Connect Pro cellular blood pressure monitor, or both. Vida's care teams gained reliable and consistent patient-generated health data, which enhanced their personalized care strategies and improved health outcomes by using these devices.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the digital therapeutics industry include 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc., and WellDoc Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • At present, companies are strategically enhancing their offerings and expanding their reach to bolster growth in the digital therapeutics market. Additionally, central to their efforts is forging partnerships with established healthcare entities and insurers, which helps integrate digital therapeutics into mainstream medical practice and increases patient accessibility. Moreover, various innovations by firms are advancing their technologies to improve patient engagement and outcomes through more personalized and effective treatments. Along with this, regulatory approvals are aggressively pursued to ensure compliance and enhance market credibility, crucial for broader adoption. Besides, companies invest in educational campaigns to raise awareness among healthcare professionals and patients about the benefits of digital therapeutics, aiming to shift perceptions and foster trust. These combined efforts are essential for driving the adoption and long-term viability of digital therapeutics in the healthcare landscape.

Key Questions Answered in This Report

  • 1.What was the size of the global digital therapeutics market in 2024?
  • 2.What is the expected growth rate of the global digital therapeutics market during 2025-2033?
  • 3.What are the key factors driving the global digital therapeutics market?
  • 4.What has been the impact of COVID-19 on the global digital therapeutics market?
  • 5.What is the breakup of the global digital therapeutics market based on the application?
  • 6.What is the breakup of the global digital therapeutics market based on the end use?
  • 7.What are the key regions in the global digital therapeutics market?
  • 8.Who are the key players/companies in the global digital therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Diabetes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Obesity
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CVD
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CNS Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Respiratory Diseases
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Smoking Cessation
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Patients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Providers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Payers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Employers
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 2Morrow Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Canary Health Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Click Therapeutics Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Mango Health Inc. (TrialCard Incorporated)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Noom Health Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Omada Health Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Pear Therapeutics, Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Propeller Health (ResMed)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Teladoc Health Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Voluntis Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 WellDoc Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2024
  • Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
  • Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
  • Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Digital Therapeutics Market: Competitive Structure
  • Table 6: Global: Digital Therapeutics Market: Key Players